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Studies that assess the connection between the prevalence of chronic diseases and continuous 
exposure to air pollution are scarce in developing countries, mainly due to data limitations. Largely 
overcoming data limitations, this study aimed to investigate the association between the likelihood of 
reporting a set of chronic diseases (diabetes, cancer, stroke and myocardial infarction, asthma, and 
hypertension) and continuous exposure to CO, NO2, O3, and PM10. Using the estimated associations, 
the disease burden and economic costs of continuous exposure to the air pollutants were also 
approximated. A 2011 HEART survey from Tehran, Iran, was used in the main analyses. A sample of 
67,049 individuals who had not changed their place of residence for at least two years before the 
survey and reported all relevant socioeconomic information was selected. The individuals were 
assigned with the average monthly air pollutant levels of the nearest of 16 air quality monitors during 
the two years leading to the survey. Both single- and multi-pollutant analyses were conducted. The 
country’s annual household surveys from 2002–2011 were used to calculate the associated economic 
losses. The single-pollutant analysis showed that a one-unit increase in monthly CO (ppm), NO2 (ppb), 
O3 (ppb) and PM10 (μg/m
3) during the two years was associated with 751 (CI: 512–990), 18 (CI: 12–
24), 46 (CI: -27–120), and 24 (CI: 13–35) more reported chronic diseases in 100,000, respectively. The 
disease-specific analyses showed that a unit change in average monthly CO was associated with 329, 
321, 232, and 129 more reported cases of diabetes, hypertension, stroke and myocardial infarction, 
and asthma in 100,000, respectively. The measured associations were greater in samples with older 
individuals. Also, a unit change in average monthly O3 was associated with 21 (in 100,000) more 
reported cases of asthma. The multi-pollutant analyses confirmed the results from single-pollutant 
analyses. The supplementary analyses showed that a one-unit decrease in monthly CO level could have 
been associated with about 208 (CI: 147–275) years of life gained or 15.195 (CI: 10.296–20.094) 
thousand USD in life-time labor market income gained per 100,000 30-plus-year-old Tehranis.   






1. Introduction  
In the past two decades, because of remarkable improvements in the quality of air pollution and health 
data, the number of studies that examined the relationship between high-cost chronic diseases and air 
pollution considerably increased. A large body of literature has shown a positive association between 
the incidence or prevalence of different types of diabetes and increased levels of ambient air pollutants 
for all age-groups (1−7). In addition, increased levels of air pollutants are shown to be positively 
associated with the increased risk of lung cancer and lung cancer mortality (8−13), stroke and 
myocardial infarction (14−19), asthma (20−22), and blood pressure and hypertension (23−25).  
One particular aspect of the new wave of research is its focus on the relationship between chronic 
diseases and long-term or continuous exposure to air pollutants. Despite short-term assessments of 
exposure that account for air pollutants’ levels in the day, week, or month of a medical examination 
or diagnosis, long-term exposure assessments account for air pollutants’ levels in prior months or 
years. Research that studied continuous exposure often considered the population of more developed 
counties and examined cancer and diabetes. There is much less research on the association of 
circulatory and respiratory diseases with continuous exposure to air pollutants, especially on 
populations of developing countries. 
Citizens of Middle Eastern and North African (MENA) megacities, such as Cairo, Istanbul, Karachi, 
and Tehran, are exposed to extraordinary levels of air pollution, much greater than the levels examined 
by the literature and the levels recommended by international and national health and environmental 
agencies (26, 27). As a result, in the MENA region, the percentage of all-cause deaths attributable to 
air pollution has consistently been greater than that in all other regions (28). As an example, Tehran 
had 218 unhealthy, very unhealthy, or hazardous days in 2011, according to the air quality index (AQI) 
reported by the City (29). While the number of such days has decreased in recent years and reached 
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108 in 2017, for example, the concentration of different air pollutants was still well above the levels 
recommended by the World Health Organization, WHO (29, 30).  
Until recently, lack of suitable data—namely, individual-level health microdata and high-frequency 
high-resolution air quality data—had made it difficult to empirically examine the relationship between 
chronic diseases and continuous exposure to the remarkably low levels of air quality in a Middle 
Eastern megacity. Largely overcoming these problems, we conducted a retrospective study to examine 
the association of continuous exposure to ambient CO, NO2, O3, and PM10—mostly traffic-
originated (26, 27)—with the likelihood of reporting diabetes, cancer, stroke and myocardial 
infarction, hypertension, and asthma among citizens of Tehran. Further, we used the estimated 
associations in the calculation of the burden of the chronic diseases in terms of the years of life lost 
and their labor and non-labor market costs.  
2. Methods 
2.1. Study population 
For individual-level health information, we used data from an urban HEART survey, designed by the 
WHO Center for Health Development and conducted by the Municipality of Tehran in October 2011. 
Collected according to a stratified multistage cluster sampling method, the HEART survey includes a 
representative sample of Tehrani households from its all 22 districts. The survey includes 33,915 
households and 118,464 individuals. The survey provides detailed information on surveyed 
individuals’ socioeconomic characteristics, access to and utilization of health care, their physical, 
physiological, mental, and social health, self-assessed quality of life, and chronic diseases such as 
diabetes, cancer, stroke and myocardial infarction, hypertension, and asthma. Most of the survey’s 
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questions pertain to the month or year leading to interview. Questions on the chronic diseases are 
accompanied by a flag variable indicating if one had the disease during the interview.  
Knowing individuals’ place of residence is the key piece of information in the approximation of their 
exposure to ambient air pollutants. The survey reports the 10-digit postal code (the exact address) of 
most households’ place of residence. For 10,122 of them, however, the postal code is either not 
reported or misreported. Socioeconomic characteristics of those with and without usable postal code 
were not different. We divided those with usable postal code (108,342 individuals) into 1,872 city areas 
according to the first five digits of the postal code. Then, we used the city’s map, provided by Iran’s 
National Cartographic Center, and the ArcGIS software and extracted geographical coordinates 
(latitude and longitude) of the middle point of the 1,872 areas. Next, using the coordinates of the five-
digit postal codes and coordinates of air quality monitors, we determined the closest monitor to each 
household.  
Another important piece of information provided by the data is the household’s length of stay in its 
current place of residence; otherwise, the assignment of exposure to ambient air pollutants would 
suffer from serious measurement error originated from households’ moves from one location to 
another. Since we accounted for exposure to air pollutants in the two years leading to the HEART 
interview dates, we limited the sample of households to those resided in their place of residence for 
at least two years. This constraint led to the dropping of 15,983 individuals.  
Among the remaining 92,359 individuals, a key piece of information, age, is not reported for 17,591 
individuals. In the rest, 74,768 individuals, we kept those who reported their chronic diseases’ status 
and socioeconomic background information, such as gender, education, economic activity, and health 
insurance. Ultimately, our final sample included 67,049 individuals. 
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2.2. Ambient air pollution data 
We used hourly ambient air pollutants’ data, collected by air quality monitors separately installed by 
Municipality of Tehran (MoT, henceforth) and the country’s Department of Environment (DoE, 
henceforth) across the city’s metropolitan area. The number and coverage of both organizations’ 
monitors have increased over time. The MoT had only one monitor in a northeast district of the city 
in 2000, installed three other monitors in two northwest districts and one in a southern district in 
2006, and expanded them to sixteen in 2011 and to twenty-two in 2018, covering almost all districts 
of the city. The DoE had six air quality monitors in 2000 but expended them to eighteen in 2018. 
In October 2011, when the HEART was underway, twenty-two monitors (sixteen from the MoT and 
six from the DoE) were collecting ambient air pollution information. The monitors did not collect 
information on the same set of pollutants. Also, sometimes they stopped working or reported 
erroneous pollutant concentration values, e.g., negative or impossibly large values. We used a 
monitor’s recorded data if they were available and acceptable for at least 75% of hours in a day and 
days in a month. Considering carbon monoxide, for example, 16, 13, 7, 5, and 3 of the 22 monitors 
continuously reported acceptable concentration levels for at least 1, 2, 3, 4, and 5 years, respectively, 
before October 2011. 
2.3. Length of exposure 
The decision on the choice of the length of exposure to air pollutants considered all the limitations 
above, especially the timing of installation of air quality monitors. Selecting shorter terms, one year, 
for example, before the HEART survey leads to using data from more monitors hence increasing the 
cross-sectional variation in air pollutants’ levels. Nonetheless, one year’s air quality can be affected by 
specific events of that year. On the other hand, if the selected period is three years or longer, the 
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number of monitors significantly decreases, so does the cross-sectional variation in the air pollutants’ 
levels. All in all, we focused on the two years before the HEART survey.  
In the two years leading to the HEART survey (i.e., October 2009 to September 2011), 16 different 
monitors reported continuous and acceptable data on ozone (O3), 15 on nitrogen dioxide (NO2), 14 
on coarse particulate matter (PM10), and 13 on carbon monoxide (CO). The monitors are scattered 
virtually evenly throughout the city, covering populations living in all districts (Figure 1). For other air 
pollutants—such as sulfur dioxide (SO2), black carbon (BC), fine particulate matter (PM2.5)—there 
were very few monitors with continuous and acceptable data to be considered in our analysis. 
2.4. Measures of exposure 
On any given day during the period, we measured an individual’s exposure to a specific air pollutant 
by its concentration level at the nearest air quality monitor to the individual’s place of residence. We 
calculated average monthly exposure levels from daily and hourly exposure values. Then, we found 
the average, median, and maximum of the 24 monthly averages. We focused on the average of the 
monthly averages because it uses all air pollution data; the median and maximum of the monthly 
averages represent data of only 30 or 31 days. Nonetheless, when median and maximum exposure 
measures were used, the results were consistent with those from the average exposure measures.         
During the two years, concentration levels of the ambient air pollutants in Tehran were remarkably 
greater than what is recommended by the WHO and other major environmental watchdogs. For 
example, the interviewees were exposed to an average monthly CO level of 3.6 ppm (parts per million), 
while the US Environmental Protection Agency (EPA) does not allow greater than 9 ppm CO level 
in only “8 hours” (31). Also, they were exposed to an average monthly NO2 level of 53.9 ppb (parts 
per billion), while the EPA enforces and the WHO recommends average “annual” levels below 53 
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and 21 ppb, respectively (30, 31). In terms of O3, the average monthly level in Tehran was 22.7 ppb, 
while the EPA enforces and the WHO recommends average “8-hourly” levels below 70 and 50 ppb, 
respectively (30, 31). For PM10, the average monthly level was 102 μg/m3, while the EPA enforces 
and the WHO recommends average daily levels below 150 and 50 μg/m3 (30, 31). 
2.5. Statistical analysis 
The concentration of the air pollutants noticeably varied across monitors. Specifically, the average 
monthly CO, NO2, O3, and PM10 levels varied in the ranges of 1.4–5.2 ppm, 22.2–91.4 ppb, 12.1–
32.7 ppb, and 58.1–137.8 μg/m3, respectively. Across groups of 30-plus-year-old individuals assigned 
to the thirteen monitors used in the CO analysis, for example, the average rate of prevalence of 
diabetes, cancer, stroke and myocardial infarction, hypertension, and asthma varied in the ranges of 
2.3%–8.1%, 0.0%–0.8%, 1.3%–5.3%, 5.6%–11.6%, and 0.8%–2.0%, respectively. For 60-plus-year-
old individuals, the corresponding variation ranges were 5.4%–21.6%, 0.1%–1.5%, 3.5%–9.1%, 
13.6%–25.6%, and 0.0%–3.1%, respectively. The average rate of prevalence of the five chronic 
diseases in the 30-plus and 60-plus years olds varied in the range o 9.6%–19.0% and 21.4%–40.5%, 
respectively. 
Such large variations in exposure to the air pollutants and the prevalence of the chronic diseases across 
the air quality monitors allow for conducting statistical analyses to investigate if there were any 
relationships between the chronic diseases and the air pollutants. We set up controlled single-pollutant 
and multi-pollutant regression analyses in which the left-hand-side variable was an indicator of 
individual’s affliction by one of the chronic diseases, and the right-hand-side variables were the 
exposure measure(s), three basic personal characteristics (age, body mass index, and gender), a set of 
key individual-level socioeconomic attributes (type of economic activity and education level), a set of 
household-level background factors (health insurance status, ownership of a car, access to computer 
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at home, and city district), and interactions of the exposure measure(s) with district-specific 
socioeconomic factors. 
Age and BMI are two known risk factors for the chronic diseases of interest (28, 32, 33). Also, male 
individuals may generally be at a higher risk of affliction (34−36). Moreover, the literature shows that 
employment and higher education are correlated with a lower probability of chronic diseases (37, 38). 
We categorized individual’s economic activity to seven types (i.e., employed, job seeker, unemployed 
with income, retired, homemaker, student, other) and education to four levels (i.e., illiterate or some 
primary school, some secondary school, high school diploma, and some college).  
We examined controlling for a host of household-level background factors such as size, total 
expenditures, savings, amenities, access to utilities, features of the residence, district of residence, and 
access to health care. As most of the household level factors are highly correlated, we included a set 
of most influential ones—namely, the city district, access to health care, having a computer at home, 
and ownership of a car—in the analysis. Summary statistics of the variables showed variations in the 
individual- and household-level socioeconomic factors across the city’s 22 districts (Tables 1-a and 1-
b, respectively, for 30-plus and 60-plus-year-old individuals), justifying controlling for the variables. 
Suspecting that a potential relationship between the likelihood of chronic diseases and exposure to air 
pollution may be nonlinear, we examined the inclusion of interactions of the measures of air pollution 
with district-specific socioeconomic factors. Specifically, we included the interactions of the exposure 
measures with an index of district-specific level of college education (set equal to 1 if the rate of college 
education among the 30-plus-year-olds at the district was greater than 20%; 0 otherwise). 
We estimated the statistical models using the ordinary least squares method. Hence, we could directly 
interpret the estimated coefficient(s) of the exposure measure(s) as the association between the 
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chronic disease of interest and the average monthly exposure to the ambient air pollutant of interest, 
in percentage. Since the left-hand-side variable in the statistical models is binary, it is common to use 
the logit regression method. We reported the estimates of linear probability models (LPM) because 1) 
their results, apart from being straightforward to interpret, could be easily used in the calculation of 
burden of diseases and economic costs; 2) the estimations of the marginal associations at means using 
logit regressions produced very similar results to what we found using LPMs; 3) more than 98% of 
our LPMs’ predicted values that fell in the 0–1 range. To account for similarities of individuals within 
each city district, we clustered standard errors at the district level (39). We estimated our LPMs in Stata 
15.0 (STATA, Inc, College Station, Texas, USA). 
In addition, we discussed the potential relationship between the estimated associations and life 
expectancy and income. Specifically, we approximated years of life lost (YLLs) due to the chronic 
diseases due to a change in the air pollutants. YLLs are metrics of premature death in a population. 
For example, the YLLs attributable to diabetes are equal to the number of deaths caused by diabetes 
in the population of interest times the standard life expectancy (taken as Japanese men’s and women’s 
life expectancy) at the age of death (40). Then, using the approximated changes in YLLs, we assessed 
the potential income gains from a persistent decrease in air pollution.  
2.6. Limitations of the statistical analysis 
Exposure to air pollution varies by household location, which itself is influenced by household wealth, 
social network, and preferences. The underlying factors can simultaneously influence the prevalence 
of chronic diseases. If they are unobserved or their influence mechanism is unaccounted, the estimated 
associations suffer from endogeneity bias.  
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By focusing on those who resided in one place in the two years before the survey, we effectively 
excluded all moves in response to a change in air quality during the period. As the possibility of such 
moves is often determined by households’ financial means and social networks, the exclusion partly 
limits the extent of the endogeneity bias—in addition to improving the accuracy of the assignment of 
exposure to individuals. Nevertheless, the choice of location before the two years can be endogenous. 
To account for the latter, information on households’ wealth and resources right before the two-year 
period is needed. Such information is not available as the HEART survey is not longitudinal. Instead, 
information on households’ “current” wealth such as its total expenditures and savings, features of 
the place of residence (e.g., ownership, number of rooms, and area), and ownership of major durables 
(e.g., car, home appliances, computer, and cellphone) is available. The magnitude of the bias depends 
on the correlation between these indicators of wealth in October 2011 and September 2009. The 
correlation is expected to be strong. However, if an unobserved factor is undermeasured by the 
indicators and is negatively correlated with both the likelihood of chronic diseases and exposure to air 
pollution, then the associations were underestimated. An example of such factors is the ownership of 
an estate in the country to escape from the city’s polluted air.       
The estimated associations may also suffer from two types of measurement errors. One is the potential 
underreporting of chronic diseases: in comparison to higher-income individuals, a larger number of 
lower-income individuals might not have known about their chronic diseases because of their limited 
access to health care. We expect controlling for health insurance status, district, education, and wealth 
indicators accounts for such underreporting. If any variation in the potential underreporting remains 
unexplained by these variables, then the associations are underestimated.  
Another potential source of measurement error is the imprecise assignment of air pollution to 
individuals because of 1) the assignment of a monitor’s measurements to all households under a 
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specific radius around it, 2) the assumption that individuals commutes took place mostly around the 
monitor, and 3) ignoring variation on indoor exposure to air pollutants. To assess the first error, we 
included household distance from the nearest monitor in the statistical model, but it did not change 
the results. The second error is stronger for those who work farther outside the coverage of their 
nearby air quality monitor. We expect controlling for economic activity type partly addresses this 
concern, but we cannot conjecture on the direction of the effect of any uncontrolled variation in such 
misassignments. To assess the third error, we compared the rates of consumption of tobacco products 
by monitor coverage and found no statistically significant difference. Further examination of the error 
requires information on household fuel type, not reported in the survey.      
3. Results 
We ran age-specific linear probability models for each of the chronic diseases (Table 2 provides the 
total number of observations and variation in reporting the chronic diseases for each of the models). 
The estimated associations between each pair of chronic disease and air pollutants from the single-
pollutant models are presented in Table (3), where each entry is a result of a separate model. We 
provided a direct, generic presentation of the results in which we assume a one-unit change in the air 
pollutants’ concentration―namely, one ppm, ppb, ppb, and μg/m3 change in CO, NO2, O3, and 
PM10, respectively. Hence, the results are easily modifiable to any given unit or any number of 
standard deviations change in concentrations simply by multiplying the presented results by the 
multiplier of interest (City- and district-level standard deviations in air pollutants’ concentrations are 
presented in Table 1). We did not change the units of the air pollutants’ measurement to the 
international system of units (SI), but the generic presentation of the results allows for easily 
reproducing them in SI (μg/m3) by multiplying the measured associations for a one ppm increase in 
CO, one ppb increase in NO2, and one ppb increase in O3 by 1.1, 1.9, and 2.0, respectively.            
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A one ppm (cross-sectional) increase in the average monthly CO (i.e., an about 25% increase over its 
overall city-level average) was associated with reporting 751 more cases of chronic diseases, in 100,000, 
regardless of age. Our age-specific estimations showed that the association noticeably increased by age 
from 1,240 to 1,870, 2,360, and 2,740 (in 100,000) for 30-plus, 40-plus, 50-plus, and 60-plus-year-old 
individuals, respectively, although the difference between the associations at the highest two age ranges 
was not statistically significant due to decrease in statistical power (Table 3). 
The main contributors to the large association between exposure to CO and the prevalence of chronic 
diseases were diabetes, hypertension, and stroke and myocardial infarction. Regardless of age, a one 
ppm increase in monthly CO was associated with 329, 321, 232 in 100,000 more reported cases of 
diabetes, hypertension, and stroke and myocardial infarction, respectively. For diabetes, the size of the 
association for 30-plus-, 40-plus-, 50-plus-, and 60-plus-year-old individuals was 528, 854, 1,380, and 
1,350 (in 100,000), respectively, where the difference between the latter two was statistically 
insignificant. For hypertension, the sizes of the corresponding associations were 574, 829, 868, and 
1,630 in 100,000, although the latter association was statistically insignificant. For stroke and 
myocardial infarction, the associations amounted to 407, 606, 833, and 901 in 100,000, respectively, 
although the latter association was statistically insignificant. We estimated an association between 
exposure to CO and asthma (185 in 100,000 increase in prevalence for a one ppm increase in monthly 
concentration) for 30-plus years olds but none between CO and cancer (Table 3).    
For NO2, one ppb increase was associated with 18 to 33 in 100,000 more cases of chronic diseases 
reported, depending on age. A 6.75 ppb increase in NO2 (equivalent to 25% increase over its city-level 
average) was associated with reporting 121 to 223 in 100,000 more cases of chronic diseases, 
depending on age. However, no statistically significant positive association between exposure to NO2 
and a specific chronic disease was measured (Table 3).  
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Like NO2, a statistically significant association between exposure to PM10 and the general likelihood 
of reporting chronic diseases but no statistically significant association for any specific disease was 
measured. The size of the overall, regardless of age association was 24 in 100,000 for a one μg/m3 
increase in PM10 or 635 in 100,000 for a 20% increase in PM10 over its city-level average (Table 3).     
Statistically significant associations between exposure to O3 and asthma were measured. Specifically, 
a one ppb increase in monthly exposure to O3 (about 4.4% over its city-level monthly average) was 
associated with an average of 21 in 100,000 increase in the prevalence of asthma. Alternatively, a 25% 
increase over the city level average of O3 concentration was associated with about 119 in 100,000 more 
reported cases of asthma. The magnitude of the association increased by age such that a 25% increase 
in O3 over its city-level average was associated with an about 267, 357, and 610 in 100,000 more cases 
of reported asthma for the 40-plus-, 50-plus-, and 60-plus-year-olds, where the latter was statistically 
insignificant (Table 3).       
We tested if the findings from single-pollutant analyses would hold under multi-pollutant analyses, 
where measures of exposure to all air pollutants were inserted at the right-hand-side of the statistical 
models. Table (4) reports the correlations between the concentration of the pollutants for air quality 
monitors whose CO levels were used in this study. In most stations for which both NO2 and CO 
levels were reported, the correlation between the two was large, sometimes well above 50%. Also, in 
most stations, the correlation between NO2 and O3 levels was rather large, in a 30%–55% range. 
Hence, suspecting that the inclusion of NO2 in the multi-pollutant regressions would lead to a 
multicollinearity problem, we excluded it. In effect, signs of multicollinearity (e.g., changes in the sign 
of some exposure measures and the size of some standard deviations) appeared with the inclusion of 
NO2.             
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Table (5) presents the results of estimating the multi-pollutant models. In effect, the results from 
single-pollutant analyses were largely confirmed by the multi-pollutant analyses. In both single- and 
multipollutant analyses, an increase in average two-yearly exposure to CO had the strongest and most 
consistent association with an increase in the likelihood of reporting chronic diseases—especially 
diabetes, hypertension, and stroke and myocardial infarction—in comparison to O3 and PM10. The 
magnitudes of the statistically significant associations from multi-pollutant analyses were very close, 
although a bit smaller as expected, than those from the single-pollutant analyses. Also, the association 
of exposure to O3 and asthma was confirmed in multi-pollutant analyses. Nonetheless, the statistically 
significant associations between exposure to PM10 and the general likelihood of reporting a chronic 
disease at ages 30- and 40-plus year disappeared in the multi-pollutant analyses. 
4. Discussion 
We related the measured associations to life expectancy (measured by YLLs) and income. We based 
the calculations on 2011 because 1) the estimated associations are for 2011 2) there is accurate 
population information for 2011 as it was a census year.  
4.1.  Potential burden of disease gains of persistent improvement in air quality 
The latest results from the Global Burden of Disease project (GBD)—annually conducted by Institute 
for Health Metrics and Evaluation (IHME)—provides estimations of the burden of 282 causes and 
the attributable burden of 84 risk factors from 1990 to 2017 (28, 32). We used the GBD’s age-specific 
estimations of YLLs attributable to the causes of interest (diabetes, stroke and myocardial infarction, 
and asthma) and the risk factor of interest (hypertension), for which we found statistically significant 
associations with one or more air pollutants. Since we did not find a statistically significant association 
between the likelihood of reporting cancer and exposure to any of the air pollutants, we excluded 
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cancer from this discussion. Also, we assumed YLLs provided for Iranians are the same as those for 
Tehranis. 
The GBD’s county- and age-specific results are provided for five-year age-groups (e.g., 30–34, 35–39, 
etc.); whereas, we estimated the associations for 30-plus-, 40-plus-, 50-plus-, and 60-plus-year-old 
individuals. To find YLLs that correspond to the age-groups of this study, we weighted the GBD’s 
estimated YLLs with the sample shares of the matching age-groups. In effect, we calculated: 
𝑌𝐿𝐿𝑠𝑙+





where 𝑙=30, 40, 50, or 60, 𝑌𝐿𝐿𝑠𝑗
𝑘 is the GBD’s estimation of YLLs attributable to the chronic 
condition 𝑘 for age-group 𝑗, and 𝜔𝑗 is the share of individuals in the age-group 𝑗 in the sample. For 
example, the YLLs attributable to diabetes among the 60-plus-year-old Iranians are calculated from: 
𝑌𝐿𝐿𝑠60+





𝑑𝑖𝑎𝑏𝑒𝑡𝑒𝑠 + 𝜔65−69. 𝑌𝐿𝐿𝑠65−69
𝑑𝑖𝑎𝑏𝑒𝑡𝑒𝑠 +⋯+𝜔90−94. 𝑌𝐿𝐿𝑠90−94
𝑑𝑖𝑎𝑏𝑒𝑡𝑒𝑠 
where the variables 𝑌𝐿𝐿𝑠60−64
𝑑𝑖𝑎𝑏𝑒𝑡𝑒𝑠, 𝑌𝐿𝐿𝑠65−69
𝑑𝑖𝑎𝑏𝑒𝑡𝑒𝑠, …, and 𝑌𝐿𝐿𝑠90−94
𝑑𝑖𝑎𝑏𝑒𝑡𝑒𝑠 are the years of life lost due to 
premature death caused by diabetes among the 60−64-, 65−69-, …, and 90−94-year-old Iranians, 
calculated and reported by the GBD (28, 32). The variables 𝜔60−64, 𝜔65−69, …, and 𝜔90−94 are the 
shares of 60−64-, 65−69-, …, and 90−94-year-old individuals in the analysis sample. Inserting the 
required numbers in the formula, average YLLs were equal to 2,508, 5,259, 541, and 14,306 in 100,000 
60-plus-year-olds, respectively, for diabetes, stroke and myocardial infarction, asthma, and 
hypertension. Table (6), panel (B), provides the results of calculating the YLLs for all age-groups.  
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Table (6), panel (A), represents the results of the multi-pollutant analyses, namely, the associations 
between a one ppm decrease in the monthly CO level during two years and decrease in the number 
of reported cases of diabetes, stroke and myocardial infarction, asthma, and hypertension in 100,000. 
We assumed that the associations also represent the associations between CO level and burden of the 
chronic conditions. For example, we assumed that a one ppm decrease in monthly CO level is 
associated with a 1,370 in 100,000 decreases in the rate of YLLs attributable to diabetes among 60-
plus-year-old Tehranis because we found the same decrease in CO was associated with 1,370 in 
100,000 decreases in the number of diabetes cases in the age-group.   
Given that the prevailing rate of YLLs among the 60-plus-year-old Tehranis was 2,508 per 100,000 
(Table 6, panel B), a one ppm decrease in monthly CO level was associated with a (1,370 / 100,000) 
× 2,508   = 34.4 in 100,000 decrease in the number of years lost due to diabetes in the age-group. The 
results of all such calculations, per 100,000, are presented in Table (6), panel (C), for all age-groups 
and chronic diseases, for the same decrease in CO.  
Using the total number of 30-plus, 40-plus, 50-plus, and 60-plus-year-old Tehranis from Census 2011 
city-level data, we transformed the decreases in the rates of YLLs to total years gained (Table 6, panel 
D). For example, for 30-plus-year-old Tehranis, the total years of life that could have been gained by 
a one ppm decrease in average monthly CO level during the two years was approximated as 208, 339, 
15, and 1,119—due to fewer cases of diabetes, stroke and myocardial infarction, asthma, and 
hypertension, respectively.  
4.2. Potential income gains of persistent improvement in air quality 
Having the estimated years of life that could have been gained due to a hypothetical one ppm decrease 
in average monthly CO level in Tehran, we calculated labor and non-labor market incomes that could 
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have been gained due to the decrease. For this purpose, we used Iranian Household Expenditure and 
Income Surveys (HEIS) conducted by the Statistical Center of Iran. The HEIS is an annual cross-
sectional survey that collects detailed information on Iranian households’ expenditures on about 1,100 
items and their dwelling’s characteristics, access to utilities, and ownership of major household items 
such as car, TV, refrigerator, air conditioner, and computer. It also provides detailed information on 
household members’ socioeconomic characteristics (e.g., gender, age, and education) and their income 
from three sources, namely 1) self-employment jobs, 2) wage and salaried jobs, and 3) non-labor, 
miscellaneous sources such as rent, interest, social security, and aids.  
We selected Tehranis surveyed by the HEIS and processed their income data. While the HEIS samples 
are large and include about 38,000 households and about 138,000 individuals—on average—each year, 
the number of Tehranis is not large enough for a credible income analysis. For example, in HEIS 
2011, 3,684 Tehranis were surveyed; among them, only 1,994 were 30 years or older. To increase the 
sample size, we processed and harmonized data from ten HEIS surveys during the ten year period 
that led to 2011. Subsequently, our sample size of 30-year plus individuals increased to 19,361. Pooling 
data from a decade also has the advantage of averaging incomes over economic up and downs hence 
decreasing the sensitivity of the analyses to particular events. We used sample weights in all labor 
market calculations, described below.   
The chance of having a job, hence labor income, during the 2002–2011 period for a 30-plus-year-old 
Tehrani was 41.7%. There was a wide gender gap in the chance of employment such that it was 72.8% 
and 10.2% for males and females, respectively. One the other hand, 24.9% of 30-plus-year-old 
Tehranis were unemployed but had income, that is, they had one or more non-labor income sources 
such as rent, interest, and social security. There was a smaller gender gap in terms of having non-labor 
income: 32.4% versus 17.3% for 30-plus-year-old males and females, respectively. The chance of 
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having labor income decreased, but that of having non-labor income increased as we restricted the 
sample to older individuals, but the gender gaps were persistent (Table 7). 
If a 30-plus-year-old Tehrani held a job during 2002–2011, then it made an annual labor market 
income of 9,387 thousand Iranian tomans (TIT) or an equivalent of 7,823 US dollars (USD), both 
assessed at 2011 prices. If the person had non-labor income, then it averaged at the annual value of 
5,984 TIT or 4,987 USD. Only about 5% of 30-plus-year-olds had both labor and non-labor income. 
In general, a 30-plus-year-old income earner made 8,834 TIT or 7,362 USD a year. Amounts of labor 
and non-labor incomes were greater in subsamples with older individuals, but a large gender gap in 
terms of the amount of both types of incomes persisted in all subsamples (Table 8).  
Using the chances of engaging in different types of activity (reported in Tables 7) and income levels 
for those who reported an income (reported in Table 8), expected income levels for 30-plus-, 40-plus-
, 50-plus-, and 60-plus-year-old Tehranis were calculated. For a 30-plus-year-old Tehrani, for example, 
the expected annual labor, non-labor, and total income levels, respectively, were 3,933, 1,483, and 
5,416 TIT—or 3,277, 1,236, and 4,513 USDs; for a 60-plus-year-old Tehrani, on the other hand, the 
expected annual labor, non-labor, and total income levels, respectively, were 1,525, 3,721, and 5,245 
TIT—or 1,271, 3,101, and 4,371 USD (Table 9).  
The potential income gains from a one ppm decrease in average monthly CO level were approximated 
from the results in Table (9) and Table 6, panel D. The estimated gains per 100,000 Tehranis, assessed 
at 2011 prices, are presented in Tables (10–1) to (10–4) where it was assumed that the labor market 
participation rates and wages in the years after 2011 would remain like those in 2002–2011 period. For 
example, the lifetime income gain for every 100,000 30-plus-year-old Tehranis from the estimated 
increase in life expectancy due to a reduction in prevalence of diabetes, strokes, asthma, and 
hypertension (in turn, due to a one ppm decrease in average monthly CO) amounted to 25.110, 40.962, 
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1.829, and 135.313 million Iranian tomans (MIT), respectively—or 20.925, 34.135, 1.524, and 112.761 
thousand USD. For 40-plus-year-old Tehranis, the corresponding projected lifetime income gains 
were 57.597, 89.830, 2.267, and 307.122 MIT in 100,000, respectively—or 47.998, 74.758, 1.889, and 
255.935 thousand USD in 100,000. These are significant amounts, even without considering potential 
improvements in quality of life. For comparison, the price of a new, popular brand of car (Pride) in 
2011 was 7.8 MIT in Iran.   
5. Conclusions 
The results of this study showed that, in comparison to other ambient air pollutants, exposure to CO 
is most consistently and significantly associated with the likelihood of reporting diabetes, stroke and 
myocardial infarction, asthma, and hypertension. The data of this analysis, however, did not provide 
sufficient statistical power to assess potential associations between air pollution and the likelihood of 
reporting cancer. Basing the burden of diseases and economic analyses on the CO results, we found 
that large public health and economic gains can be achieved with a continuous decrease in air pollution. 
One potential policy to achieve such gains is adjusting the country’s fuel prices, which have historically 
been among the lowest in the world. For example, adjusting the gas price can reduce the concentration 
of CO, as vehicles are a major source of CO emission. Such an adjustment once took place in 2017 
and resulted in an about 18% decrease in the average annual concentration of CO, which had remained 
unchanged from 2011, in Tehran (29).    
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Table 1-a: Number of observations, average monthly air pollution levels, the prevalence of chronic diseases, and individual and household 




Table 1-b: Number of observations, average monthly air pollution levels, the prevalence of chronic diseases, and individual and household 










Diabetes Cancer Stroke Hypertension Asthma 
All Ages 1 9.0% 2.6% 0.3% 1.4% 5.3% 1.0% 
 0 91.0% 97.4% 99.7% 98.6% 94.7% 99.0% 
  N 67,049 67,049 67,049 67,049 67,049 67,049 
30+ Year Olds 1 14.8% 4.4% 0.5% 2.3% 9.0% 1.3% 
 0 85.2% 95.6% 99.5% 97.7% 91.0% 98.7% 
  N 39,371 39,371 39,371 39,371 39,371 39,371 
40+ Year Olds 1 19.6% 5.8% 0.6% 3.1% 12.1% 1.6% 
 0 80.4% 94.2% 99.4% 96.9% 87.9% 98.4% 
  N 28,203 28,203 28,203 28,203 28,203 28,203 
50+ Year Olds 1 25.9% 7.7% 0.8% 4.5% 16.4% 1.9% 
 0 74.1% 92.3% 99.2% 95.5% 83.6% 98.1% 
  N 17,724 17,724 17,724 17,724 17,724 17,724 
60+ Year Olds 1 32.1% 9.1% 1.1% 6.2% 20.9% 2.3% 
 0 67.9% 90.9% 98.9% 93.8% 79.1% 97.7% 





Table 3: (single-pollutant regressions): Number of people with a chronic disease per 100,000 per 1 







Diabetes Cancer Stroke Hypertension Asthma 
All Ages CO 751.0*** 329.0*** 10.6 232.0*** 321.0* 129.0** 
  (239.0) (76.1) (44.2) (85.5) (164.0) (52.6) 
 NO2 18.2*** 9.9 0.6 5.7 9.2 -1.5 
  (5.8) (7.1) (1.4) (4.8) (6.6) (2.1) 
 O3 46.1 15.5 -5.2 -7.1 23.1 20.8* 
  (73.5) (15.2) (7.6) (21.8) (58.8) (12.0) 
 PM10 23.6** 5.4 1.5 6.4 8.8 2.7 
  (11.1) (6.5) (1.4) (4.7) (6.5) (6.0) 
  N 67,049 67,049 67,049 67,049 67,049 67,049 
30+ Year Olds CO 1240.0*** 528.0*** 22.3 407.0** 574.0* 185.0** 
  (407.0) (153.0) (75.7) (144.0) (293.0) (83.0) 
 NO2 29.0*** 17.5 1.3 9.7 12.9 -3.1 
  (8.1) (13.0) (1.9) (7.9) (10.5) (3.0) 
 O3 62.7 17.8 -11.7 -10.5 47.7 21.4 
  (115.0) (26.1) (14.4) (38.5) (95.3) (18.6) 
 PM10 33.1* 9.1 2.3 10.9 12.8 -0.5 
  (17.4) (11.3) (2.4) (7.9) (11.7) (9.1) 
  N 39,371 39,371 39,371 39,371 39,371 39,371 
40+ Year Olds CO 1870.0** 854.0*** 29.6 606.0** 829.0* 210.0 
  (676.0) (208.0) (118.0) (227.0) (418.0) (136.0) 
 NO2 33.0** 24.7 1.6 11.0 17.6 -8.7 
  (11.7) (18.2) (2.4) (10.8) (14.1) (5.2) 
 O3 61.7 31.9 -24.5 -25.1 27.4 46.8* 
  (165.0) (29.8) (23.3) (58.4) (132.0) (22.9) 
 PM10 23.6** 18.0 5.4 15.4 21.4 -0.8 
  (28.8) (16.1) (3.8) (11.8) (18.4) (16.0) 
  N 28,203 28,203 28,203 28,203 28,203 28,203 
50+ Year Olds CO 2360.0* 1380.0*** 48.2 833.0** 868.0 251.0 
  (1,190.0) (349.0) (168.0) (358.0) (879.0) (169.0) 
 NO2 25.2* 32.2 3.6 10.5 13.5  -12.8* 
  (14.1) (28.1) (2.5) (16.3) (17.8) (7.4) 
 O3 157.0 66.4 -16.3 -43.8 73.3 62.7* 
  (264.0) (58.8) (29.1) (109.0) (191.0) (35.0) 
 PM10 71.8 23.3 6.5 23.8 22.1 -1.3 
  (45.4) (23.2) (5.5) (18.2) (35.9) (19.2) 
  N 17,724 17,724 17,724 17,724 17,724 17,724 
60+ Year Olds CO 2740.0 1350.0** -43.4 901.0 1630.0 271.0 
  (1,830.0) (637.0) (248.0) (798.0) (1,810.0) (305.0) 
 NO2 15.1 49.8 1.7 23.7 -24.6  -21.2* 
  (23.4) (47.3) (2.2) (34.2) (20.5) (10.5) 
 O3 111.0 42.4 -69.6 -135.0 96.5 107.0 
  (373.0) (115.0) (59.8) (140.0) (268.0) (75.9) 
 PM10 66.5 32.4 5.1 11.8 51.9 -20.5 
  (60.6) (33.1) (9.7) (33.2) (54.2) (33.5) 
  N 8,635 8,635 8,635 8,635 8,635 8,635 
Notes: Numbers in parentheses are standard errors. ***, **, and * indicate 1%, 5%, and 10% levels of statistical significance.  
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Table 4: The Pearson correlation coefficient of the trends of average monthly concentration levels 
of every two air pollutants by air quality monitor 
Air Quality 
Monitor 
CO CO CO NO2 NO2 O3 
vs. vs. vs. vs. vs. vs. 
NO2 O3 PM10 O3 PM10 PM10 
1 0.69 0.00  -  0.30  -   -  
2 0.48 0.37 0.12 0.35 0.21 0.46 
3 0.78 0.50  -  0.12  -   -  
4 0.80 0.22 0.34 0.09 0.29 0.14 
5  -  0.25 0.41  -   -  0.15 
6 0.74 0.54 0.53 0.55 0.47 0.06 
7 0.07 0.43 0.02 0.46 0.17 0.03 
8  -  0.25 0.27  -   -  0.12 
9 0.69 0.32 0.39 0.46 0.02 0.07 
10  -  0.27 0.39  -   -  0.38 
11 0.42 0.04 0.17 0.25 0.41 0.35 
12 0.44 0.24 0.25 0.44 0.37 0.13 
13  -  0.31 0.20  -   -  0.06 




















Table 5 (multi-pollutant regressions): Number of people with a chronic disease per 100,000 per 1 




Any Chronic Diabetes Cancer Stroke Hypertension Asthma 
All Ages CO 687.0*** 329.0*** 17.3 259.0*** 291.0* 96.4* 
  (194.0) (85.0) (47.7) (80.0) (146.0) (54.6) 
 NO2 - - - - - - 
  - - - - - - 
 O3 -9.5 -6.9 -7.5 -26.9 0.5 13.9 
  (77.2) (10.4) (8.6) (20.0) (61.5) (14.6) 
 PM10 18.4* 3.0 1.7 5.4 6.4 1.4 
  (10.5) (6.0) (1.4) (3.6)  (6.6) (6.0) 
  N 67,049 67,049 67,049 67,049 67,049 67,049 
30+ Year Olds CO 1180.0*** 538.0*** 39.7 447.0*** 518.0** 174.0* 
  (305.0) (173.0) (81.3) (137.0) (242.0) (92.4) 
 NO2 - - - - - - 
  - - - - - - 
 O3 -27.4 -18.9 -16.1 -44.5 10.2 12.7 
  (115.0) (17.1) (15.5) (35.8) (97.5) (22.1) 
 PM10 24.0 5.2 2.6 8.9 7.9 -2.5 
  (16.9) (10.8) (2.4) (6.1) (12.1) (9.0) 
  N 39,371 39,371 39,371 39,371 39,371 39,371 
40+ Year Olds CO 1820.0*** 850.0*** 58.9 685.0*** 815.0** 155.0 
  (499.0) (213.0) (128.0) (212.0) (357.0) (146.0) 
 NO2 - - - - - - 
  - - - - - - 
 O3 -82.4 -29.1 -33.3 -77.1 -34.8 40.9 
  (163.0) (18.2) (24.6) (53.4) (136.0) (25.2) 
 PM10 40.7 11.3 6.4 12.5 15.3 -4.2 
  (27.0) (15.7) (4.0) (9.3) (17.7) (16.5) 
  N 28,203 28,203 28,203 28,203 28,203 28,203 
50+ Year Olds CO 2140.0** 1380.0*** 63.0 960.0*** 772.0 170.0 
  (816.0) (369.0) (185.0) (292.0) (671.0) (181.0) 
 NO2 - - - - - - 
  - - - - - - 
 O3 -19.7 -28.9 -26.1 -120.0 13.3 56.7* 
  (234.0) (45.4) (32.2) (104.0) (175.0) (31.7) 
 PM10 53.8 12.4 7.1 20.9 14.7 -5.4 
  (40.5) (22.6) (6.3) (15.4) (31.4) (19.7) 
  N 17,724 17,724 17,724 17,724 17,724 17,724 
60+ Year Olds CO 2710.0* 1370.0* 71.6 1290.0 1500.0 186.0 
  (1,420.0) (695.0) (294.0) (864.0) (1,790.0) (327.0) 
 NO2 - - - - - - 
  - - - - - - 
 O3 -110.0 -68.6 -80.9 -230.0 -37.0 117.0* 
  (337.0) (106.0) (61.7) (164.0) (267.0) (66.4) 
 PM10 45.6 22.4 7.8 9.3 39.3 -27.2 
  (50.1) (35.5) (10.5) (28.2) (44.6) (35.4) 
  N 8,635 8,635 8,635 8,635 8,635 8,635 
Notes: Numbers in parentheses are standard errors. ***, **, and * indicate 1%, 5%, and 10% levels of statistical significance.  
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Table 6: Potential YYLs gains from a 1 ppm decrease in average monthly CO level over two years 
  Diabetes Stroke Asthma Hypertension 
A: Change in Reporting Chronic Diseases (in 100,000), Results from  
the Multi-Pollutant Analyses 
30 Years or Older 538 447 174 518 
 (173) (81) (137) (242) 
40 Years or Older 850 685 155 815 
 (213) (128) (212) (357) 
50 Years or Older 1,380 960 170 772 
 (369) (185) (292) (671) 
60 Years or Older 1,370 1,290 186 1,500 
 (695) (294) (864) (1,790) 
B: Calculated YLLs Using Results of the GBD Project (in 100,000) 
30 Years or Older 862 1,692 194 4,823 
 (12) (17) (2) (91) 
40 Years or Older 1,172 2,268 253 6,517 
 (17) (24) (3) (125) 
50 Years or Older 1,709 3,289 354 9,411 
 (26) (37) (5) (191) 
60 Years or Older 2,508 5,259 541 14,306 
 (47) (69) (9) (350) 
C: Change in YLLs (in 100,000) 
30 Years or Older 4.6 7.6 0.3 25.0 
 (1.5) (1.4) (0.3) (11.7) 
40 Years or Older 10.0 15.5 0.4 53.1 
 (2.5) (2.9) (0.5) (23.3) 
50 Years or Older 23.6 31.6 0.6 72.7 
 (6.3) (6.1) (1.0) (63.2) 
60 Years or Older 34.4 67.8 1.0 214.6 
 (17.4) (15.5) (4.7) (256.2) 
D: Total Change in YLLs 
30 Years or Older 208 339 15 1,119 
 (67) (62) (12) (523) 
40 Years or Older 299 467 12 1,596 
 (75) (87) (16) (700) 
50 Years or Older 430 575 11 1,324 
 (115) (111) (19) (1,151) 
60 Years or Older 319 630 9 1,992 
  (162) (144) (43) (2,378) 





Table 7: Distribution of individuals in terms of activity by age and gender (Tehranis surveyed during 
2002–2011) 
  Number    Unemployed, Unemployed   Home-   
  of Obs Employed Job Seeker with Income Student maker Other 
30 Years or Older 
pooled 19,269 41.7% 2.0% 18.5% 0.4% 36.2% 1.3% 
males 9,681 72.8% 3.2% 21.9% 0.1% 0.2% 1.8% 
females 9,588 10.2% 0.7% 15.1% 0.8% 72.6% 0.7% 
40 Years or Older 
pooled 13,258 36.0% 1.4% 26.2% 0.2% 34.7% 1.5% 
males 6,716 63.9% 2.4% 31.2% 0.1% 0.2% 2.2% 
females 6,542 7.4% 0.2% 21.1% 0.3% 70.1% 0.9% 
50 Years or Older 
pooled 7,908 26.2% 1.0% 39.9% 0.0% 30.9% 2.1% 
males 4,116 47.3% 1.7% 47.8% 0.0% 0.3% 2.9% 
females 3,792 3.2% 0.1% 31.2% 0.0% 64.1% 1.3% 
60 Years or Older 
pooled 4,058 15.3% 0.8% 54.8% 0.0% 25.6% 3.5% 
males 2,196 27.6% 1.4% 66.4% 0.0% 0.4% 4.3% 






Table 8: Average inflation-adjusted annual labor and non-labor income of a Tehrani with reported 
income by age and gender during 2002–2011 in 2011 thousand Iranian tomans and US dollar 
  Thousand Iranian Toman   US dollar 
 Labor Non-Labor    Labor Non-Labor   
 Market Market Total  Market Market Total 
  Income Income Income   Income Income Income 
 30 Years or Older 
Pooled 9,387 5,984 8,834  7,823 4,987 7,362 
 (143) (79) (109)   (119) (66) (90) 
N 7,976 4,798 11,870   7,976 4,798 11,870 
Males 9,844 6,443 9,708   8,204 5,369 8,090 
 (158) (108) (133)   (132) (90)  (111) 
N 7,022 3,136 9,304   7,022 3,136 9,304 
Females 6,028 5,118 5,669   5,023 4,265 4,724 
 (251) (97) (125)   (209) (81)  (104) 
N 954 1,662 2,566   954 1,662 2,566 
 40 Years or Older 
Pooled 10,285 6,135 9,140  8,571 5,113 7,617 
 (228) (81) (145)   (190) (67)  (120) 
N 4,745 4,498 8,446   4,745 4,498 8,446 
Males 10,708 6,631 10,186   8,923 5,526 8,489 
 (246) (110) (181)   (205) (92)  (151) 
N 4,278 2,946 6,485   4,278 2,946 6,485 
Females 6,418 5,194 5,682   5,348 4,328 4,735 
 (483) (100) (141)   (403) (83)  (118) 
N 467 1,552 1,961   467 1,552 1,961 
 50 Years or Older 
Pooled 10,552 6,303 8,615  8,794 5,253 7,179 
 (426) (86) (191)   (355) (72)  (159) 
N 2,056 3,809 5,364   2,056 3,809 5,364 
Males 10,793 6,885 9,738   8,994 5,737 8,115 
 (450) (117) (253)   (375) (98)  (211) 
N 1,939 2,517 3,976   1,939 2,517 3,976 
Females 6,578 5,171 5,402   5,481 4,310 4,502 
 (516) (102) (108)   (430) (85) (90) 
N 117 1,292 1,388   117 1,292 1,388 
 60 Years or Older 
Pooled 10,009 6,128 7,420  8,341 5,107 6,183 
 (851) (111) (242)   (709) (92)  (202) 
N 615 2,518 2,933   615 2,518 2,933 
Males 10,158 6,738 8,423   8,465 5,615 7,019 
 (870) (152) (332)   (725)  (126)  (277) 
N 601 1,696 2,102   601 1,696 2,102 
Females 3,599 4,871 4,888   2,999 4,059 4,074 
 (870) (122) (122)   (725)  (102)  (102) 
N 14 822 831   14 822 831 
Notes: Numbers in parentheses are standard deviations.   
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Table 9: Expected inflation-adjusted annual labor and non-labor income of a Tehrani by age and 
gender during 2002–2011 in 2011 thousand Iranian tomans and US dollar 
  Thousand Iranian Toman   US dollar 
 Labor Non-Labor    Labor Non-Labor   
 Market Market Total  Market Market Total 
  Income Income Income   Income Income Income 
 30 Years or Older 
Pooled 3,933 1,483 5,416  3,277 1,236 4,513 
 (68) (27) (73)  (57) (23) (61) 
N 19,361 19,361 19,361   19,361 19,361 19,361 
Males 7,210 2,078 9,288   6,008 1,732 7,740 
 (123) (46) (129)   (102) (39)  (107) 
N 9,723 9,723 9,723   9,723 9,723 9,723 
Females 627 883 1,510   522 736 1,258 
 (34) (26) (42)  (28) (22) (35) 
N 9,638 9,638 9,638   9,638 9,638 9,638 
 40 Years or Older 
Pooled 3,714 2,068 5,782  3,095 1,723 4,818 
 (91) (37) (99)  (76) (31) (83) 
N 13,350 13,350 13,350   13,350 13,350 13,350 
Males 6,882 2,892 9,774   5,735 2,410 8,145 
 (168) (63) (176)   (140) (52)  (147) 
N 6,758 6,758 6,758   6,758 6,758 6,758 
Females 468 1,223 1,691   390 1,019 1,409 
 (40) (36) (53)  (33) (30) (44) 
N 6,592 6,592 6,592   6,592 6,592 6,592 
 50 Years or Older 
Pooled 2,775 3,002 5,777  2,312 2,502 4,814 
 (121) (54) (136)   (101) (45)  (113) 
N 8,000 8,000 8,000   8,000 8,000 8,000 
Males 5,143 4,168 9,312   4,286 3,474 7,760 
 (226) (88) (244)   (188) (74)  (203) 
N 4,158 4,158 4,158   4,158 4,158 4,158 
Females 213 1,740 1,953   177 1,450 1,627 
 (25) (52) (57)  (20) (44) (48) 
N 3,842 3,842 3,842   3,842 3,842 3,842 
 60 Years or Older 
Pooled 1,525 3,721 5,245  1,271 3,101 4,371 
 (137) (82) (179)   (115) (68)  (149) 
N 4,150 4,150 4,150   4,150 4,150 4,150 
Males 2,803 5,109 7,912   2,335 4,258 6,593 
 (252) (130) (315)   (210)  (108)  (263) 
N 2,238 2,238 2,238   2,238 2,238 2,238 
Females 30 2,097 2,127   25 1,748 1,773 
 (10) (76) (77)  (8) (64) (64) 
N 1,912 1,912 1,912   1,912 1,912 1,912 
Notes: Numbers in parentheses are standard deviations.  
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Table 10–1 (diabetes): Life-time income gained due to the decrease in the burden of diabetes 
associated with a 1 ppm decrease in average monthly CO level over two years (per 100,000)  
  Million Iranian Toman   Thousand US dollar 
 Labor Non-Labor    Labor Non-Labor   
 Market Market Total  Market Market Total 
  Income Income Income   Income Income Income 
 30 Years or Older 
Pooled 18.234 6.876 25.110  15.195 5.730 20.925 
 (5.879) (2.217) (8.091)  (4.899) (1.848) (6.742) 
Males 33.429 9.635 43.064  27.857 8.029 35.887 
 (10.777) (3.110) (13.876)  (8.981) (2.591) (11.563) 
Females 2.907 4.094 7.001  2.422 3.412 5.834 
  (0.950) (1.324) (2.263)   (0.792) (1.103) (1.886) 
 40 Years or Older 
Pooled 36.999 20.598 57.597  30.833 17.165 47.998 
 (9.335) (5.184) (14.494)  (7.779) (4.320) (12.078) 
Males 68.558 28.808 97.366  57.132 24.007 81.139 
 (17.295) (7.260) (24.507)  (14.413) (6.050) (20.423) 
Females 4.661 12.185 16.846  3.884 10.154 14.038 
  (1.240) (3.081) (4.263)   (1.033) (2.567) (3.553) 
 50 Years or Older 
Pooled 65.439 70.794 136.233  54.533 58.995 113.528 
 (17.776) (19.009) (36.642)  (14.813) (15.841) (30.535) 
Males 121.300 98.305 219.605  101.083 81.921 183.004 
 (32.955) (26.420) (59.123)  (27.462) (22.017) (49.269) 
Females 5.015 41.035 46.050  4.179 34.196 38.375 
  (1.471) (11.065) (12.414)   (1.226) (9.221) (10.345) 
 60 Years or Older 
Pooled 52.387 127.832 180.218  43.655 106.526 150.182 
 (27.120) (64.980) (91.762)  (22.600) (54.150) (76.468) 
Males 96.287 175.530 271.818  80.239 146.275 226.515 
 (49.841) (89.263) (138.542)  (41.534) (74.385) (115.452) 
Females 1.044 72.047 73.090  0.870 60.039 60.909 
  (0.646) (36.698) (37.229)  (0.539) (30.582) (31.024) 







Table 10–2 (strokes & myocardial infarction): Life-time income gained due to the decrease in the 
burden of strokes associated with a 1 ppm decrease in average monthly CO level over two years (per 
100,000)   
  Million Iranian Toman   Thousand US dollar 
 Labor Non-Labor    Labor Non-Labor   
 Market Market Total  Market Market Total 
  Income Income Income   Income Income Income 
 30 Years or Older 
Pooled 29.744 11.218 40.962  24.787 9.348 34.135 
 (5.444) (2.054) (7.484)  (4.537) (1.712) (6.236) 
Males 54.532 15.717 70.250  45.444 13.098 58.541 
 (9.979) (2.886) (12.836)  (8.316) (2.405) (10.697) 
Females 4.742 6.679 11.421  3.952 5.566 9.517 
  (0.903) (1.233) (2.105)   (0.752) (1.027) (1.755) 
 40 Years or Older 
Pooled 57.705 32.125 89.830  48.087 26.771 74.858 
 (10.897) (6.041) (16.886)  (9.081) (5.034) (14.072) 
Males 106.925 44.929 151.854  89.104 37.441 126.545 
 (20.188) (8.468) (28.558)  (16.823) (7.056) (23.799) 
Females 7.269 19.004 26.273  6.057 15.837 21.894 
  (1.500) (3.602) (4.988)   (1.250) (3.002) (4.157) 
 50 Years or Older 
Pooled 87.614 94.783 182.396  73.011 78.986 151.997 
 (17.356) (18.380) (35.482)  (14.463) (15.317) (29.569) 
Males 162.402 131.616 294.018  135.335 109.680 245.015 
 (32.180) (25.567) (57.300)  (26.817) (21.306) (47.750) 
Females 6.714 54.940 61.654  5.595 45.783 51.378 
  (1.518) (10.739) (12.044)   (1.265) (8.949) (10.037) 
 60 Years or Older 
Pooled 103.433 252.393 355.827  86.194 210.328 296.522 
 (25.477) (57.904) (82.188)  (21.231) (48.253) (68.490) 
Males 190.112 346.571 536.683  158.427 288.809 447.236 
 (46.804) (79.641) (124.474)  (39.004) (66.367) (103.728) 
Females 2.061 142.251 144.311  1.717 118.542 120.259 
  (0.817) (32.908) (33.380)   (0.681) (27.424) (27.817) 







Table 10–3 (asthma): Life-time income gained due to the decrease in the burden of asthma 
associated with a 1 ppm decrease in average monthly CO level over two year (per 100,000) 
  Million Iranian Toman   Thousand US dollar 
 Labor Non-Labor    Labor Non-Labor   
 Market Market Total  Market Market Total 
  Income Income Income   Income Income Income 
 30 Years or Older 
Pooled 1.328 0.501 1.829  1.107 0.417 1.524 
 (1.046) (0.395) (1.440)  (0.872) (0.329) (1.200) 
Males 2.435 0.702 3.136  2.029 0.585 2.614 
 (1.918) (0.553) (2.470)  (1.598) (0.461) (2.059) 
Females 0.212 0.298 0.510  0.176 0.248 0.425 
  (0.167) (0.235) (0.402)   (0.139) (0.196) (0.335) 
 40 Years or Older 
Pooled 1.456 0.811 2.267  1.214 0.676 1.889 
 (1.993) (1.109) (3.102)  (1.661) (0.924) (2.585) 
Males 2.699 1.134 3.833  2.249 0.945 3.194 
 (3.693) (1.552) (5.244)  (3.078) (1.293) (4.370) 
Females 0.183 0.480 0.663  0.153 0.400 0.553 
  (0.252) (0.657) (0.908)   (0.210) (0.547) (0.756) 
 50 Years or Older 
Pooled 1.668 1.804 3.472  1.390 1.504 2.893 
 (2.869) (3.100) (5.967)  (2.391) (2.583) (4.972) 
Males 3.091 2.505 5.597  2.576 2.088 4.664 
 (5.317) (4.305) (9.619)  (4.431) (3.588) (8.016) 
Females 0.128 1.046 1.174  0.106 0.871 0.978 
  (0.221) (1.798) (2.017)   (0.185) (1.498) (1.681) 
 60 Years or Older 
Pooled 1.534 3.744 5.278  1.278 3.120 4.398 
 (7.158) (17.396) (24.534)  (5.965) (14.497) (20.445) 
Males 2.820 5.140 7.960  2.350 4.284 6.634 
 (13.155) (23.889) (37.012)  (10.963) (19.908) (30.843) 
Females 0.031 2.110 2.140  0.025 1.758 1.784 
  (0.149) (9.809) (9.951)   (0.124) (8.174) (8.292) 







Table 10–4 (hypertension): Life-time income gained due to the decrease in the burden of 
hypertension associated with a 1 ppm decrease in average monthly CO level over two year (per 
100,000) 
  Million Iranian Toman   Thousand US dollar 
 Labor Non-Labor    Labor Non-Labor   
 Market Market Total  Market Market Total 
  Income Income Income   Income Income Income 
 30 Years or Older 
Pooled 98.257 37.056 135.313  81.881 30.880 112.761 
 (45.987) (17.345) (63.310)  (38.323) (14.454) (52.758) 
Males 180.141 51.921 232.061  150.117 43.267 193.384 
 (84.309) (24.314) (108.579)  (70.257) (20.262) (90.483) 
Females 15.664 22.062 37.727  13.054 18.385 31.439 
  (7.385) (10.342) (17.681)   (6.155) (8.618) (14.734) 
 40 Years or Older 
Pooled 197.289 109.833 307.122  164.408 91.528 255.935 
 (86.681) (48.214) (134.807)  (72.234) (40.178) (112.340) 
Males 365.568 153.610 519.178  304.640 128.009 432.648 
 (160.610) (67.462) (227.908)  (133.842) (56.218) (189.923) 
Females 24.852 64.974 89.825  20.710 54.145 74.855 
  (11.142) (28.570) (39.511)   (9.285) (23.808) (32.926) 
 50 Years or Older 
Pooled 201.591 218.086 419.677  167.992 181.739 349.731 
 (175.687) (189.717) (365.181)  (146.406) (158.097) (304.317) 
Males 373.673 302.836 676.509  311.394 252.363 563.758 
 (325.666) (263.480) (588.752)  (271.389) (219.566) (490.627) 
Females 15.448 126.412 141.859  12.873 105.343 118.216 
  (13.640) (110.041) (123.482)   (11.366) (91.701) (102.902) 
 60 Years or Older 
Pooled 327.197 798.411 1,125.608  272.664 665.343 938.007 
 (393.344) (953.650) (1,345.244)  (327.787) (794.708) (1,121.037) 
Males 601.392 1,096.329 1,697.722  501.160 913.608 1,414.768 
 (722.939) (1,309.676) (2,029.714)  (602.449) (1,091.396) (1,691.429) 
Females 6.519 449.990 456.509  5.432 374.992 380.424 
  (8.418) (537.868) (545.653)   (7.015) (448.223) (454.711) 
Notes: Numbers in parentheses are standard deviations. 
 
